The complexity of ERK1 and ERK2 MAPKs in multiple hepatocyte fate responses

Journal of Cellular Physiology

Volumn 227, Issue 1, 2012, Pages 59-69

  Frémin, Christophe ^a,b,c   Ezan, Frédéric ^a,b,c   Guegan, Jean Philippe ^a,b,c   Gailhouste, Luc ^a,b,c   Trotard, Maud ^a,b,c   Le Seyec, Jacques ^a,b,c   Rageul, Julie ^a,b,c   Theret, Nathalie ^a,b,c   Langouët, Sophie ^a,b,c   Baffet, Georges ^a,b,c  

^a UNIVERSITÉ DE RENNES 1   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; ALBUMIN; ALDOLASE B; CYTOCHROME P450 1A2; CYTOCHROME P450 2B2; CYTOCHROME P450 3A; CYTOCHROME P450 3A23; EPIDERMAL GROWTH FACTOR; FRUCTOSE BISPHOSPHATE ALDOLASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHENOBARBITAL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; LIVER CELL; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SURVIVAL TIME;

ANIMALS; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; EPIDERMAL GROWTH FACTOR; HEPATOCYTES; IMMUNOBLOTTING; MALE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 80054895601     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22742     Document Type: Review

References (48)

1. Allan LA, Morrice N, Brady S, Magee G, Pathak S, Clarke PR. 2003. Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nat Cell Biol 5:647-654.
2. Andrieux L, Langouet S, Fautrel A, Ezan F, Krauser JA, Savouret JF, Guengerich FP, Baffet G, Guillouzo A. 2004. Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes. Mol Pharmacol 65:934-943.
3. Bessard A, Coutant A, Rescan C, Ezan F, Fremin C, Courselaud B, Ilyin G, Baffet G. 2006. An MLCK-dependent window in late G1 controls S phase entry of proliferating rodent hepatocytes via ERK-p70S6K pathway. Hepatology 44:152-163.
4. Bessard A, Fremin C, Ezan F, Fautrel A, Gailhouste L, Baffet G. 2008. RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo. Oncogene 27:5315-5325.
5. Bissell DM, Arenson DM, Maher JJ, Roll FJ. 1987. Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver. J Clin Invest 79:801-812.
6. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME. 1999. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286:1358-1362.
7. Bost F, Aouadi M, Caron L, Even P, Belmonte N, Prot M, Dani C, Hofman P, Pages G, Pouyssegur J, Le Marchand-Brustel Y, Binetruy B. 2005. The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 54:402-411.
8. Bourcier C, Jacquel A, Hess J, Peyrottes I, Angel P, Hofman P, Auberger P, Pouyssegur J, Pages G. 2006. p44 Mitogen-activated protein kinase (extracellular signal-regulated kinase 1)-dependent signaling contributes to epithelial skin carcinogenesis. Cancer Res 66:2700-2707.
9. Burke MD, Mayer RT. 1983. Differential effects of phenobarbitone and 3-methylcholanthrene induction on the hepatic microsomal metabolism and cytochrome P-450-binding of phenoxazone and a homologous series of its n-alkyl ethers (alkoxyresorufins). Chem Biol Interact 45:243-258.
10. Clayton DF, Darnell JE, Jr. 1983. Changes in liver-specific compared to common gene transcription during primary culture of mouse hepatocytes. Mol Cell Biol 3:1552-1561.
11. Coutant A, Rescan C, Gilot D, Loyer P, Guguen-Guillouzo C, Baffet G. 2002. PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival. Hepatology 36:1079-1088.
12. Danielsen AJ, Maihle NJ. 2002. The EGF/ErbB receptor family and apoptosis. Growth Factors 20:1-15.
13. Eisenmann KM, VanBrocklin MW, Staffend NA, Kitchen SM, Koo HM. 2003. Mitogen-activated protein kinase pathway-dependent tumor-specific survival signaling in melanoma cells through inactivation of the proapoptotic protein bad. Cancer Res 63:8330-8337.
14. Elbashir SM, Harborth J, Weber K, Tuschl T. 2002. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26:199-213.
15. Evan G, Littlewood T. 1998. A matter of life and cell death. Science 281:1317-1322.
16. Fassett JT, Tobolt D, Nelsen CJ, Albrecht JH, Hansen LK. 2003. The role of collagen structure in mitogen stimulation of ERK, cyclin D1 expression, and G1-S progression in rat hepatocytes. J Biol Chem 278:31691-31700.
17. Fischer AM, Katayama CD, Pages G, Pouyssegur J, Hedrick SM. 2005. The role of erk1 and erk2 in multiple stages of T cell development. Immunity 23:431-443.
18. Fraslin JM, Kneip B, Vaulont S, Glaise D, Munnich A, Guguen-Guillouzo C. 1985. Dependence of hepatocyte-specific gene expression on cell-cell interactions in primary culture. EMBO J 4:2487-2491.
19. Fremin C, Ezan F, Boisselier P, Bessard A, Pages G, Pouyssegur J, Baffet G. 2007. ERK2 but not ERK1 plays a key role in hepatocyte replication: An RNAi-mediated ERK2 knockdown approach in wild-type and ERK1 null hepatocytes. Hepatology 45:1035-1045.
20. Fremin C, Bessard A, Ezan F, Gailhouste L, Regeard M, Le Seyec J, Gilot D, Pages G, Pouyssegur J, Langouet S, Baffet G. 2009. Multiple division cycles and long-term survival of hepatocytes are distinctly regulated by extracellular signal-regulated kinases ERK1 and ERK2. Hepatology 49:930-939.
21. Gailhouste L, Ezan F, Bessard A, Fremin C, Rageul J, Langouet S, Baffet G. 2009. RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo. Int J Cancer 126:1367-1377.
22. Guguen Guillouzo C. 2002. Isolation and culture of animals and human hepatocytes. New York: John Wiley and Sons Inc.
23. Guguen-Guillouzo C, Szajnert MF, Glaise D, Gregori C, Schapira F. 1981. Isozyme differentiation of aldolase and pyruvate kinase in fetal, regenerating, preneoplastic, and malignant rat hepatocytes during culture. In Vitro 17:369-377.
24. Guillouzo A. 1998. Liver cell models in in vitro toxicology. Environ Health Perspect 106:511-532.
25. Hansen LK, Wilhelm J, Fassett JT. 2006. Regulation of hepatocyte cell cycle progression and differentiation by type I collagen structure. Curr Top Dev Biol 72:205-236.
26. Harada H, Quearry B, Ruiz-Vela A, Korsmeyer SJ. 2004. Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity. Proc Natl Acad Sci USA 101:15313-15317.
27. Hatano N, Mori Y, Oh-hora M, Kosugi A, Fujikawa T, Nakai N, Niwa H, Miyazaki J, Hamaoka T, Ogata M. 2003. Essential role for ERK2 mitogen-activated protein kinase in placental development. Genes Cells 8:847-856.
28. Isom I, Georgoff I, Salditt-Georgieff M, Darnell JE, Jr. 1987. Persistence of liver-specific messenger RNA in cultured hepatocytes: Different regulatory events for different genes. J Cell Biol 105:2877-2885.
29. Langouet S, Coles B, Morel F, Becquemont L, Beaune P, Guengerich FP, Ketterer B, Guillouzo A. 1995. Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture. Cancer Res 55:5574-5579.
30. Lefloch R, Pouyssegur J, Lenormand P. 2007. Single and combined ERK1/ERK2 silencing reveals their positive contribution to growth signaling depending on their expression levels. Mol Cell Biol 28:511-527.
31. Lips DJ, Bueno OF, Wilkins BJ, Purcell NH, Kaiser RA, Lorenz JN, Voisin L, Saba-El-Leil MK, Meloche S, Pouyssegur J, Pages G, De Windt LJ, Doevendans PA, Molkentin JD. 2004. MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. Circulation 109:1938-1941.
32. Liu X, Yan S, Zhou T, Terada Y, Erikson RL. 2004. The MAP kinase pathway is required for entry into mitosis and cell survival. Oncogene 23:763-776.
33. Loyer P, Cariou S, Glaise D, Bilodeau M, Baffet G, Guguen-Guillouzo C. 1996. Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro. Evidence of a mitogen restriction point in mid-late G1. J Biol Chem 271:11484-11492.
34. Maeda S, Kimura H, Koga N, Lin KH, Saito T. 1993. Cell density-dependent DNA fragmentation and its suppression by heparin in primary culture of adult rat hepatocytes. Biochem Biophys Res Commun 195:270-275.
35. Michalopoulos GK, Bowen WC, Mule K, Stolz DB. 2001. Histological organization in hepatocyte organoid cultures. Am J Pathol 159:1877-1887.
36. Padgham CR, Paine AJ, Phillips IR, Shephard EA. 1992. Maintenance of total cytochrome P-450 content in rat hepatocyte culture and the abundance of CYP1A2 and CYP2B1/2 mRNAs. Biochem J 285:929-932.
37. Pages G, Guerin S, Grall D, Bonino F, Smith A, Anjuere F, Auberger P, Pouyssegur J. 1999. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 286:1374-1377.
38. Reiners JJ, Jr, Lee JY, Clift RE, Dudley DT, Myrand SP. 1998. PD98059 is an equipotent antagonist of the aryl hydrocarbon receptor and inhibitor of mitogen-activated protein kinase kinase. Mol Pharmacol 53:438-445.
39. Rescan C, Coutant A, Talarmin H, Theret N, Glaise D, Guguen-Guillouzo C, Baffet G. 2001. Mechanism in the sequential control of cell morphology and S phase entry by epidermal growth factor involves distinct MEK/ERK activations. Mol Biol Cell 12:725-738.
40. Saba-El-Leil MK, Vella FD, Vernay B, Voisin L, Chen L, Labrecque N, Ang SL, Meloche S. 2003. An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development. EMBO Rep 4:964-968.
41. Serandour AL, Loyer P, Garnier D, Courselaud B, Theret N, Glaise D, Guguen-Guillouzo C, Corlu A. 2005. TNFalpha-mediated extracellular matrix remodeling is required for multiple division cycles in rat hepatocytes. Hepatology 41:478-486.
42. Shin S, Dimitri CA, Yoon SO, Dowdle W, Blenis J. 2010. ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events. Mol Cell 38:114-127.
43. Stennicke HR, Salvesen GS. 1997. Biochemical characteristics of caspases-3, -6, -7, and -8. J Biol Chem 272:25719-25723.
44. Talarmin H, Rescan C, Cariou S, Glaise D, Zanninelli G, Bilodeau M, Loyer P, Guguen-Guillouzo C, Baffet G. 1999. The mitogen-activated protein kinase kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G(1) phase progression in proliferating hepatocytes. Mol Cell Biol 19:6003-6011.
45. Taub R. 2004. Liver regeneration: From myth to mechanism. Nat Rev Mol Cell Biol 5:836-847.
46. Vantaggiato C, Formentini I, Bondanza A, Bonini C, Naldini L, Brambilla R. 2006. ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. J Biol 5:14.
47. Voisin L, Saba-El-Leil MK, Julien C, Fremin C, Meloche S. 2010. Genetic demonstration of a redundant role of extracellular signal-regulated kinase 1 (ERK1) and ERK2 mitogen-activated protein kinases in promoting fibroblast proliferation. Mol Cell Biol 30:2918-2932.
48. Yao Y, Li W, Wu J, Germann UA, Su MS, Kuida K, Boucher DM. 2003. Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation. Proc Natl Acad Sci USA 100:12759-12764.